Table 1.

Comparison of motor and non-motor symptoms in MSA patients with and without SRBD.

Characteristics	All MSA patients (n = 66)	With SRBD (n = 52)	Without SRBD (n = 14)	p
Male/Female	40/26	31/21	9/5	0.753
Age(years)	63.05 ± 10.13	63.69 ± 9.60	60.64 ± 11.58	0.325
Disease onset (year)	60.15 ± 10.3	60.74 ± 9.91	57.93 ± 11.01	0.370
Disease duration (year)	2.79 ± 2.78	2.61 ± 1.86	2.84 ± 2.98	0.962
UMSARS I	13.23 ± 5.8	13.06 ± 5.74	13.86 ± 5.99	0.648
UMSARS II	16.52 (12–20.25)	16.33 ± 6.12	17.29 ± 6.23	0.638
UMSARS IV	1.74 ± 0.99	1.65 ± 0.84	2.00 ± 1.36	0.751
NMSS	49.35 ± 26.4	49.79 ± 26.23	47.71 ± 28.16	0.797
HAMA	11.14 ± 7.88	10.84 ± 7.29	12.21 ± 9.64	0.804
HAMD	10.28 ± 6.99	9.78 ± 6.14	12.07 ± 9.23	0.642
ESS	7.11 (2.75–11.00)	7.23 (2.25–11.75)	6.64 (2.75–9.00)	0.571
FSS	21.71 (11–30)	22.98 (11–34)	17 (12.50–21.25)	0.723
MMSE	24.58 (22–29)	24.13 (21.25–28)	26.21 (24.50–29.00)	0.172
PLMS (%)	47 (71.2)	35 (67.3)	12 (85.7)	0.318
PSQI	6.64 (3.0–9.5)	6.90 (3–9)	5.64 (1.75–10.00)	0.194

ESS, Epworth Sleepiness Scales; FSS, Fatigue severity scale; HAMA, Hamilton anxiety scale; HAMD, Hamilton depression scale; MSA, Multiple system atrophy; MMSE, Mini-mental state examination; NMSS, Non-motor symptoms scale; PLMS, Periodic limb movements syndrome; PSQI, Pittsburgh sleep quality index; SRBD, Sleep related breathing disordered; and UMSARS, Unified multiple-system atrophy rating scale.

Values are n (%), mean ± SD or median (interquartile range).